Transphorm, Inc. – NASDAQ:TGAN
Founder-led company
Transphorm stock price today
$5.1
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 1 day
Transphorm stock price monthly change
+3.87%
month
Transphorm stock price quarterly change
+3.87%
quarter
Transphorm stock price yearly change
+28.46%
year
Transphorm key metrics
Market Cap | 323.12M |
Enterprise value | 192.34M |
P/E | -8.02 |
EV/Sales | 10.54 |
EV/EBITDA | -7.90 |
Price/Sales | 10.97 |
Price/Book | 7.10 |
PEG ratio | -0.14 |
EPS | -0.19 |
Revenue | 24.02M |
EBITDA | -12.00M |
Income | -12.78M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -146.92% |
Oper. margin | -136.42% |
Gross margin | 0.07% |
EBIT margin | -136.42% |
EBITDA margin | -49.98% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeTransphorm stock price history
Transphorm stock forecast
Transphorm financial statements
| Sep 2021 | 11.30M | 5.98M | 52.91% |
|---|---|---|---|
| Dec 2021 | 4.60M | -4.16M | -90.44% |
| Mar 2022 | 4.92M | -5.54M | -112.44% |
| Mar 2023 | 3.19M | -9.05M | -283.74% |
| Mar 2023 | 3.19M | -9.05M | -283.74% |
|---|---|---|---|
| Sep 2025 | 13.6M | -5.50M | -40.46% |
| Dec 2025 | 14.3M | -4.89M | -34.2% |
| Mar 2026 | 7.25M | -6.11M | -84.23% |
Analysts Price target
Financials & Ratios estimates
| Jun 2022 | 63730000 | 21.79M | 34.19% |
|---|---|---|---|
| Sep 2022 | 57950000 | 21.60M | 37.28% |
| Dec 2022 | 49245000 | 21.06M | 42.77% |
| Mar 2023 | 44452000 | 24.83M | 55.87% |
| Sep 2021 | -3.82M | -1.12M | 5M |
|---|---|---|---|
| Dec 2021 | -5.29M | -965K | 44.77M |
| Mar 2022 | -5.68M | -813K | -409K |
| Mar 2023 | -7.92M | -2.05M | 2.41M |
Transphorm alternative data
| Aug 2023 | 126 |
|---|---|
| Sep 2023 | 131 |
| Oct 2023 | 131 |
| Nov 2023 | 131 |
| Dec 2023 | 129 |
| Jan 2024 | 129 |
| Feb 2024 | 129 |
| Mar 2024 | 128 |
| Apr 2024 | 128 |
| May 2024 | 128 |
| Jun 2024 | 128 |
| Jul 2024 | 128 |
Transphorm other data
11.06%
-53.14%
of TGAN is owned by hedge funds
24
-19
6.27M
-30.07M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jul 2023 | 1735988 | 0 |
| Nov 2023 | 0 | 15388 |
| Jan 2024 | 0 | 4257 |
| Feb 2024 | 0 | 13992 |
| Apr 2024 | 0 | 2081 |
| May 2024 | 0 | 7992 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | MCFARLAND KATHARINA G. director | Common Stock | 3,996 | $4.89 | $19,548 | ||
Sale | SMALES KELLY director | Common Stock | 3,996 | $4.89 | $19,548 | ||
Sale | MCFARLAND KATHARINA G. director | Common Stock | 840 | $4.85 | $4,074 | ||
Sale | SMALES KELLY director | Common Stock | 475 | $4.85 | $2,304 | ||
Sale | SMALES KELLY director | Common Stock | 766 | $4.9 | $3,753 | ||
Sale | PARIKH PRIMIT director, officer.. | Common Stock | 6,000 | $4.8 | $28,806 | ||
Sale | MCFARLAND KATHARINA G. director | Common Stock | 3,996 | $4.81 | $19,225 | ||
Sale | SMALES KELLY director | Common Stock | 3,996 | $4.81 | $19,225 | ||
Sale | SMALES KELLY director | Common Stock | 471 | $4.82 | $2,271 | ||
Sale | MCFARLAND KATHARINA G. director | Common Stock | 833 | $4.82 | $4,015 |
| Quarter | Transcript |
|---|---|
| Q2 2024 10 Nov 2023 | Q2 2024 Earnings Call Transcript |
| Q1 2024 14 Aug 2023 | Q1 2024 Earnings Call Transcript |
| Q4 2023 27 Jun 2023 | Q4 2023 Earnings Call Transcript |
| Q2 2023 12 Nov 2022 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Mr. Mario Alberto Rivas (1955) Chief Executive Officer & Director | $361,850 |
| Dr. Primit A. Parikh Ph.D. (1972) Co-Founder, Pres & Chief Operating Officer | $300,000 |
Dr. Umesh K. Mishra Ph.D. (1957) Co-Founder, Chairman & Chief Technology Officer | $180,000 |
-
What's the price of Transphorm stock today?
One share of Transphorm stock can currently be purchased for approximately $5.1.
-
When is Transphorm's next earnings date?
Unfortunately, Transphorm's (TGAN) next earnings date is currently unknown.
-
Does Transphorm pay dividends?
No, Transphorm does not pay dividends.
-
How much money does Transphorm make?
Transphorm has a market capitalization of 323.12M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 31.35% to 16.51M US dollars.
-
What is Transphorm's stock symbol?
Transphorm, Inc. is traded on the NASDAQ under the ticker symbol "TGAN".
-
What is Transphorm's primary industry?
Company operates in the Technology sector and Semiconductors industry.
-
How do i buy shares of Transphorm?
Shares of Transphorm can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Transphorm's key executives?
Transphorm's management team includes the following people:
- Mr. Mario Alberto Rivas Chief Executive Officer & Director(age: 70, pay: $361,850)
- Dr. Primit A. Parikh Ph.D. Co-Founder, Pres & Chief Operating Officer(age: 53, pay: $300,000)
- Dr. Umesh K. Mishra Ph.D. Co-Founder, Chairman & Chief Technology Officer(age: 68, pay: $180,000)
-
Is Transphorm founder-led company?
Yes, Transphorm is a company led by its founders Dr. Primit A. Parikh Ph.D. and Dr. Umesh K. Mishra Ph.D..
-
How many employees does Transphorm have?
As Jul 2024, Transphorm employs 128 workers.
-
When Transphorm went public?
Transphorm, Inc. is publicly traded company for more then 5 years since IPO on 29 Jul 2020.
-
What is Transphorm's official website?
The official website for Transphorm is transphormusa.com.
-
Where are Transphorm's headquarters?
Transphorm is headquartered at 75 Castilian Drive, Goleta, CA.
-
How can i contact Transphorm?
Transphorm's mailing address is 75 Castilian Drive, Goleta, CA and company can be reached via phone at 805 456 1300.
Transphorm company profile:
Transphorm, Inc.
transphormusa.comExchange:
NASDAQ
Full time employees:
128
Industry:
Semiconductors
Sector:
Technology
Transphorm, Inc., a semiconductor company, develops, manufactures, and sells gallium nitride (GaN) semiconductor components for use in power conversion in Mainland China, Hong Kong, Taiwan, the United States, Japan, South Korea, and Europe. The company's products include GaN field effect transistors in various packages. Its GaN devices allows customers to design power systems creating functional value in various end products, including smartphone power adapters/fast-chargers, power supplies for datacenter servers/communication, industrial power converters, chargers/converters/inverters for electric vehicles, and other applications. The company offers its products through regional distributors and sales representatives. Transphorm, Inc. was founded in 2007 and is headquartered in Goleta, California.
75 Castilian Drive
Goleta, CA 93117
Goleta, CA 93117
CIK: 0001715768
ISIN: US89386L1008
CUSIP: 89386L100
